Regenerative Biotechnology
Gencell® Renal Stabilizer
Melatonin-pretreated mesenchymal stem cells for renal regenerative support.
Injectable solution of mesenchymal stem cells pretreated with melatonin, with immunomodulatory, antioxidant, and regenerative properties, indicated as adjunct therapy in renal, inflammatory, infectious, and systemic conditions.
Composition
Mesenchymal stem cells pretreated with melatonin.
Pharmaceutical form
Injectable solution.
Presentation
Single-dose vial, 4 ml.
Therapeutic properties
Promote tissue repair through immunomodulation, inflammation reduction, apoptosis inhibition, antioxidant activation, secretion of regenerative factors, and cellular stabilization enhanced by melatonin pretreatment.
- Reduction of systemic inflammation.
- Immune response modulation.
- Cellular antioxidant protection.
- Inhibition of tissue apoptosis.
- Stimulation of renal regeneration.
- Cell membrane stabilization.
- Activation of regenerative pathways.
- Support for accelerated tissue recovery.
Mechanism of action & Clinical data
Migrate to the site of injury, modulate inflammation, inhibit apoptosis, and release antioxidant and regenerative factors induced by melatonin.